Skip to content

Author

D. Kim

We have 6 of 67 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Net clinical benefit of continued oral anticoagulants after successful AF ablation: a nationwide cohort study

Current guidelines recommend individual oral anticoagulant (OAC) decision after catheter ablation for atrial fibrillation (AF) based on stroke risk. However, recent randomized trials suggest that OAC discontinuation following successful ablation may be feasible in selected patients. Real-world evidence on the net...

Y. Lee, P.-S. Yang, E. Jang et al. · 0 citations
Open access Oct 2026

Electrocardiographic aging based on artificial intelligence and the risk of heart failure and its subtypes: a multi-national study

Artificial intelligence-derived ECG aging was associated with a higher risk of incident HF across multinational cohorts and demonstrated similar magnitude risk increases across EF-defined HF subtypes, suggesting that ECG aging captures a generalized HF vulnerability signal not confined to a particular EF phenotype or b...

S. Chung, Seng-Chan You, S. Cho et al. · 0 citations
Open access Oct 2026

Digital twin virtual atrial fibrillation dynamics predict clinical atrial arrhythmia recurrence after catheter ablation

The maximal slope of the action potential duration restitution curve (Smax) reflects electrical instability and relates to fibrillation maintenance. However, the clinical significance of digital twin–derived high-density (HD) Virtual Restitution properties and Virtual atrial fibrillation (AF) sustainability in pa...

T. Hwang, D. Ahn, J. Huh et al. · 0 citations
Open access Oct 2026

Extra-pulmonary vein drivers as a potential mechanism of the antiarrhythmic drug-resistant atrial fibrillation after catheter ablation: Digital twin-guided virtual drug test

Findings suggest that persistent extra-PV PS drivers may contribute to AAD-resistant AA recurrence after PVI, and limited suppression of stable PS area under Virtual AADs, but not restitution response, predicts 3-year Clinical AA recurrence.

T. Hwang, D. Ahn, K. Im et al. · 0 citations
Open access Aug 2026

Pathway Modeling of Genomic and Tissue-Specific Transcriptomic Architecture Identifies Personalized Mechanisms of Atrial Fibrillation Risk

A pathway-level multi-omics representation learning framework that converts individual genetic profiles into interpretable biological features by integrating GWAS-derived pathway burden scores with tissue-specific transcriptomic pathway signals is developed, providing a framework for interpretable genomic stratificatio...

R. Venkatesh, R. Deo, T. Cappola et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.